切换至 "中华医学电子期刊资源库"

中华结直肠疾病电子杂志 ›› 2019, Vol. 08 ›› Issue (06) : 627 -630. doi: 10.3877/cma.j.issn.2095-3224.2019.06.015

所属专题: 文献

综述

结肠癌CME与D3根治术:平面与血管之争
黄泉龙1, 金英虎1, 王贵玉1,()   
  1. 1. 150000 哈尔滨医科大学附属第二医院结直肠肿瘤外科
  • 收稿日期:2018-12-27 出版日期:2019-12-25
  • 通信作者: 王贵玉
  • 基金资助:
    吴阶平医学基金会(No. 320.6750.15183)

Radical resection of colon cancer with CME and D3: controversy between plane and blood vessel

Quanlong Huang1, Yinghu Jin1, Guiyu Wang1,()   

  1. 1. Department of Colorectal Cancer Surgery, Second Affiliated Hospital of Harbin Medical University, Harbin 150000, China
  • Received:2018-12-27 Published:2019-12-25
  • Corresponding author: Guiyu Wang
  • About author:
    Corresponding author: Wang Guiyu, Email:
引用本文:

黄泉龙, 金英虎, 王贵玉. 结肠癌CME与D3根治术:平面与血管之争[J]. 中华结直肠疾病电子杂志, 2019, 08(06): 627-630.

Quanlong Huang, Yinghu Jin, Guiyu Wang. Radical resection of colon cancer with CME and D3: controversy between plane and blood vessel[J]. Chinese Journal of Colorectal Diseases(Electronic Edition), 2019, 08(06): 627-630.

目前,大量的回顾性研究证实对结肠癌患者行结肠癌完整系膜切除(CME)和D3根治术是可行的并且均有较理想的预后,可降低肿瘤复发率以及提高五年生存率。较传统手术,患者从结肠癌CME和D3根治术中可获得更大受益。但结肠癌CME和D3根治术两者由于概念与手术强调重点不同,在临床应用中存在着争议。本文主要根据结肠癌CME和D3根治术的方法以及国内外大量相关文献的报道进行阐述。

At present, a large number of retrospective studies confirmed colon cancer complete mesocolic excision (CME) and D3 resection are feasible and ideal, which could reduce the recurrence rate and improve the 5-year survival rate. Compared with traditional surgery, patients could benefit more from CME and D3 colon cancer resection. However, there are controversies in the clinical application of colon cancer CME and D3 radical operation because of the different emphasis on the concept and operation. This article is mainly about the methods of CME and D3 radical resection of colon cancer and the reports of a large number relevant literature.

图1 根据日本结肠直肠癌协会(Japanese Society for Cancer of the Colon and Rectum,JSCCR)淋巴结分级,D1淋巴结以红色表示,D2淋巴结以蓝色表示,D3淋巴结以黄色表示(修改自日本指南[16,17]
图2 结肠切除和淋巴结清扫范围[8]。JSCCR推荐(红色),Hohenberger提出的CME联合CVL(蓝色)
[1]
陈万青,孙可欣,郑荣寿. 2014年中国分地区恶性肿瘤发病和死亡分析[J]. 中国肿瘤,2018,27(1):1-14.
[2]
陆爱国,宗雅萍.腹腔镜右半结肠癌D3根治术[J].外科理论与实践, 2014, 19(2): 104-107.
[3]
Jacobs M, Verdeja JC, Goldstein HS. Minimally invasive colon resection (laparoscopic colectomy) [J]. Surg Laparosc Endosc, 1991, 1(3): 144-150.
[4]
Feng B, Sun J, Ling TL. Laparoscopic complete mesocolic excision (CME) with medial access for right-hemi colon cancer: feasibility and technical strategies [J]. Surg Endosc, 2012, 26(12): 3669-3675.
[5]
房学东,陈学博,季福建. 腹腔镜右半结肠癌根治规范化相关问题[J/CD].中华普外科手术学杂志:电子版,2015,9(1):18-22.
[6]
Hohenberger W, Weber K, Matzel K. Standardized surgery for colonic cancer: complete mesocolic excision and central ligation-technical notes and outcome [J]. Colorectal Dis, 2010, 11(4): 354-364.
[7]
Shin JW, Amar AH, Kim SH. Complete mesocolic excision with D3 lymph node dissection in laparoscopic colectomy for stages Ⅱ and Ⅲ colon cancer: long-term oncologic outcomes in 168 patients [J]. Tech Coloproctol, 2014, 18(9): 795-803.
[8]
Pedrazzani C, Lauka L, Sforza S. Management of nodal disease from colon cancer in the laparoscopic era [J]. Int J Colorectal Dis, 2015, 30(3): 303-314.
[9]
龚建平.右半结肠癌根治术的外科膜解剖[J/CD].中华结直肠疾病电子杂志, 2015, 4(6): 600-601.
[10]
Abdelkhalek M, Setit A, Bianco F. Complete mesocolic excision With central vascular ligation in comparison With conventional surgery for patients with colon cancer-the experiences at two centers [J]. Ann Coloproctol, 2018, 34(4): 180-186.
[11]
Panaccio P, Grottola T, Ricciardiello M. How we do it: totally laparoscopic complete mesocolon excision for splenic flexure cancer [J]. Langenbecks Arch Surg, 2018, 403(6): 769-775.
[12]
Bertelsen CA, Elfeki H, Neuenschwander AU. The risk of long-term bowel dysfunction after resection for sigmoid adenocarcinoma: a cross-sectional survey comparing complete mesocolic excision with conventional surgery [J]. Colorectal Dis, 2018, 20(9): O256-O266.
[13]
Bernhoff R, Sjövall A, Buchli C. Complete mesocolic excision in right-sided colon cancer does not increase severe short-term postoperative adverse events [J]. Colorectal Dis, 2018, 20(5): 383-389.
[14]
Kobayashi H, West NP, Takahashi K. Quality of surgery for stage III colon cancer: comparison between England,Germany, and Japan [J]. Ann Surg Oncol, 2014, 21(3): 398-404.
[15]
林锋,李勇. 腹腔镜右半结肠癌根治术[J].中国实用外科杂志, 2011, 31(9): 861-866.
[16]
Watanabe T, Itabashi M, Shimada Y. Japanese society for cancer of the colon and rectum (JSCCR) guidelines 2010 for the treatment of colorectal cancer [J]. Int J Clin Oncol, 2012, 17(1): 1-29.
[17]
Japanese Society for Cancer of the Colon and Rectum. Japanese classification of colorectal carcinoma [S]. 2nd English Edition, Tokyo: Kanehara, 2009.
[18]
Kanemitsu Y, Komori K, Kimura K. D3 Lymph node dissection in right hemicolectomy with a no-touch isolation technique in patients with colon cancer [J]. Dis Colon Rectum, 2013, 56(7): 815-824.
[19]
Hashiguchi Y, Hase K, Ueno H. Optimal margins and lymphadenectomy in colonic cancer surgery [J]. Br J Surg, 2011, 98(8): 1171-1178.
[20]
West NP, Kobayashi H, Takahashi K. Understanding optimal colonic cancer surgery: comparison of Japanese D3 resection and European complete mesocolic excision with central vascular ligation [J]. J Clin Oncol, 2012, 30(15): 1763-1769.
[21]
Xie D, Yu C, Gao C, et al. An optimal approach for laparoscopic D3 lymphadenectomy plus complete mesocolic excision (D3+CME) for right-sided colon cancer [J]. Ann Surg Oncol, 2017, 24(5): 1312-1313.
[22]
West NP, Hohenberger W, Weber K. Complete mesocolic excision with central vascular ligation produces an oncologically superior specimen compared with standard surgery for carcinoma of the colon [J]. J Clin Oncol, 2010, 28(2): 272-278.
[23]
叶颖江,高志冬,王杉. 腹腔镜完整结肠系膜切除术的应用和评价[J/CD].中华普外科手术学杂志:电子版,2015,9(1):14-17.
[1] 燕速, 霍博文, 徐惠宁. 4K荧光腹腔镜扩大右半结肠CME+D3根治术及No.206、No.204组淋巴结清扫术[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 14-14.
[2] 姚宏伟, 魏鹏宇, 高加勒, 张忠涛. 不断提高腹腔镜右半结肠癌D3根治术的规范化[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 1-4.
[3] 杜晓辉, 崔建新. 腹腔镜右半结肠癌D3根治术淋巴结清扫范围与策略[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 5-8.
[4] 周岩冰, 刘晓东. 腹腔镜右半结肠癌D3根治术消化道吻合重建方式的选择[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 9-13.
[5] 徐伯麒, 陶亮, 章帆, 毛忠琦. 结肠癌患者淋巴结转移预测模型的建立[J]. 中华普外科手术学杂志(电子版), 2023, 17(04): 393-397.
[6] 符谨诚, 李彦庆, 王亮, 邹科见. 巨大结肠脂肪瘤伴急性肠套叠一例并文献复习[J]. 中华普外科手术学杂志(电子版), 2023, 17(03): 347-348.
[7] 蓝冰, 王怀明, 王辉, 马波. 局部晚期结肠癌膀胱浸润的研究进展[J]. 中华结直肠疾病电子杂志, 2023, 12(06): 505-511.
[8] 侯文运, 刘恒昌, 窦利州, 陈海鹏, 郑朝旭, 王贵齐, 王锡山. 腹部无辅助切口内镜引导下取标本的腹腔镜辅助右半结肠癌根治术(保留回盲部)(附视频)[J]. 中华结直肠疾病电子杂志, 2023, 12(05): 436-440.
[9] 唐新, 刁德昌, 廖伟林, 林佳鑫, 汪佳豪, 李文娟, 谢嘉欣, 敖琳, 李洪明, 易小江, 卢新泉, 冯晓创. 保留神经的鞘外游离技术在腹腔镜右半结肠癌D3根治术中的近远期疗效分析:基于倾向性评分匹配的回顾性队列研究[J]. 中华结直肠疾病电子杂志, 2023, 12(05): 372-380.
[10] 陈润芝, 杨东梅, 徐慧婷. 信迪利单抗联合索凡替尼后线治疗MSS型BRAF突变的转移性结肠癌:个案报道并文献复习[J]. 中华结直肠疾病电子杂志, 2023, 12(05): 431-435.
[11] 常远, 白杨, 王文秀, 孙振强, 周全博, 崔雯铭, 王玉行, 袁维堂, 胡军红. 电子结肠镜辅助经结肠取标本手术在结肠肿瘤中的临床应用分析[J]. 中华结直肠疾病电子杂志, 2023, 12(03): 196-199.
[12] 邓振汝, 林树文, 吕泽坚, 郑佳彬, 廖乾超, 冯伙伦, 吴德庆, 王俊江, 李勇. 横结肠切除与扩大结肠切除治疗横结肠癌疗效比较[J]. 中华结直肠疾病电子杂志, 2023, 12(03): 214-220.
[13] 路继永, 王帅, 张成仁, 吴德望, 杨熊飞. 腹腔镜右半结肠切除应用现状[J]. 中华结直肠疾病电子杂志, 2023, 12(03): 221-227.
[14] 李峻峰, 李军, 孙勤丰, 孙建光, 孔祥兴. 九例结肠髓样癌的临床病理特征分析[J]. 中华结直肠疾病电子杂志, 2023, 12(03): 248-252.
[15] 徐正, 苏昊, 包满都拉, 罗寿, 张岳阳, 关旭, 张明光, 赵志勋, 梁建伟, 刘正, 刘骞, 王锡山, 周海涛. 经末段回肠系膜后隧道完成重叠式三角吻合的结肠脾曲癌完全腹腔镜左半结肠切除术23例临床分析[J]. 中华结直肠疾病电子杂志, 2023, 12(03): 253-259.
阅读次数
全文


摘要